Works matching IS 21686149 AND DT 2025 AND VI 82 AND IP 2

Results: 15
    1
    2
    3
    4
    5
    6

    An Acetylcholine M<sub>1</sub> Receptor–Positive Allosteric Modulator (TAK-071) in Parkinson Disease With Cognitive Impairment: A Phase 2 Randomized Clinical Trial.

    Published in:
    JAMA Neurology, 2025, v. 82, n. 2, p. 152, doi. 10.1001/jamaneurol.2024.4519
    By:
    • Shanbhag, Niraj M.;
    • Padmanabhan, Jaya L.;
    • Zhang, Zheng;
    • Harel, Brian T.;
    • Jia, Hongxia;
    • Kangarloo, Tairmae;
    • Yin, Wei;
    • Dowling, Ariel V.;
    • Laurenza, Antonio;
    • Khudyakov, Polyna;
    • Galinsky, Kevin;
    • Latzman, Robert D.;
    • Simuni, Tanya;
    • Weintraub, Daniel;
    • Horak, Fay B.;
    • Lustig, Cindy;
    • Maruff, Paul;
    • Simen, Arthur A.
    Publication type:
    Article
    7
    8
    9

    Blood-Based Biomarkers for Identifying Disease Activity in AQP4-IgG–Positive Neuromyelitis Optica Spectrum Disorder.

    Published in:
    JAMA Neurology, 2025, v. 82, n. 2, p. 168, doi. 10.1001/jamaneurol.2024.4400
    By:
    • Kim, Su-Hyun;
    • Gomes, Ana Beatriz Ayroza Galvão Ribeiro;
    • Schindler, Patrick;
    • Hyun, Jae-Won;
    • Kim, Ki Hoon;
    • Lee, Dong-Eun;
    • Schoeps, Vinicius Andreoli;
    • Matos, Aline de Moura Brasil;
    • Mendes, Natalia Trombini;
    • Apóstolos-Pereira, Samira Luisa Dos;
    • Callegaro, Dagoberto;
    • Lerner, Jasmine;
    • Benkert, Pascal;
    • Kuhle, Jens;
    • Ruprecht, Klemens;
    • Paul, Friedemann;
    • Pröbstel, Anne-Katrin;
    • Kim, Ho Jin
    Publication type:
    Article
    10
    11

    Quality Improvement Intervention for Reducing Acute Treatment Times in Ischemic Stroke: A Cluster Randomized Clinical Trial.

    Published in:
    JAMA Neurology, 2025, v. 82, n. 2, p. 160, doi. 10.1001/jamaneurol.2024.4304
    By:
    • Hansen, Daniël;
    • den Hartog, Sanne J.;
    • van Leeuwen, Nikki;
    • Boiten, Jelis;
    • Dinkelaar, Wouter;
    • van Doormaal, Pieter J.;
    • Eijkenaar, Frank;
    • Emmer, Bart J.;
    • van Es, Adriaan C. G. M.;
    • Flach, H. Zwenneke;
    • Gons, Rob;
    • den Hertog, M. Heleen;
    • Imani, Farshad;
    • Janssen, Paula M.;
    • Kortman, Hans;
    • Kruyt, Nyika D.;
    • Kuhrij, Laurien S.;
    • van der Leij, Christiaan;
    • Lo, T. H. Rob;
    • van der Lugt, Aad
    Publication type:
    Article
    12

    Discontinuation of First-Line Disease-Modifying Therapy in Patients With Stable Multiple Sclerosis: The DOT-MS Randomized Clinical Trial.

    Published in:
    JAMA Neurology, 2025, v. 82, n. 2, p. 123, doi. 10.1001/jamaneurol.2024.4164
    By:
    • Coerver, Eline M. E.;
    • Fung, Wing Hee;
    • de Beukelaar, Janet;
    • Bouvy, Willem H.;
    • Canta, Leo R.;
    • Gerlach, Oliver H. H.;
    • Hoitsma, Elske;
    • Hoogervorst, Erwin L. J.;
    • de Jong, Brigit A.;
    • Kalkers, Nynke F.;
    • van Kempen, Zoé L. E.;
    • Lövenich, Harry;
    • van Munster, Caspar E. P.;
    • van Oosten, Bob W.;
    • Smolders, Joost;
    • Vennegoor, Anke;
    • Zeinstra, Esther M. P. E.;
    • Barrantes-Cepas, Mar;
    • Kooij, Gijs;
    • Schoonheim, Menno M.
    Publication type:
    Article
    13
    14
    15